Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The progressive accumulation of mutated genes in cancer cells facilitates tumor immune escape. Photothermal immunotherapy addresses this problem by triggering immunogenic cell death (ICD) through photothermal treatment, releasing endogenous immunogenic neoantigens. Herein, guided by the "multi-rotor & multi-conjugation" concept, near-infrared region II (NIR-II) cyanine molecules are designed with varying numbers of benzene rotors. TPE-CyA, with more benzene rotors, features an ultra-high molar extinction coefficient (1.786 × 10 m cm), a well-balanced fluorescence quantum yield (0.99%), and a 45.72% photothermal conversion efficiency. TPE-CyA nanoparticles (TPE-CyA NPs) are ideal for high-resolution NIR-II fluorescence imaging and angiography. Imaging-guided TPE-CyA NPs show great potential in NIR-II photothermal immunotherapy by effectively suppressing bilateral tumor growth and liver metastasis without additional immunoadjuvants. Moreover, the photothermal immunotherapy guided by TPE-CyA NPs can induce ICD, promote dendritic cell (DCs) maturation, increase T-cell infiltration in tumors, and activate systemic immunity to prevent metastasis and recurrence. This research highlights the potential of NIR-II photothermal therapy in tumor cell ablation, immune activation for cancer and vascular diagnostics, presenting a novel strategy for both primary and metastatic cancers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/smll.202508447 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CpG ODN Combined with Gold Nanorods Enhances Immune Activation and Its Potential Mechanism.
J Inflamm Res
September 2025
Department of the Head and Neck, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, People's Republic of China.
Background: Immune escape of tumor cells is a common problem with tumor photothermal therapy utilizing gold nanorods (Au NRs). Whether CpG ODN, an immune adjuvant, can synergize with Au NRs to activate the immune response and its potential mechanism is not clear.
Methods: The effect of Au NRs combined with CpG ODN (Au NRs-C) on the activity of various immune-related cells, such as double-positive T cells, macrophages, NK cells, Th17, and Treg.
Metallothionein 2A-Silencing Antimonene-Based Nanoagonist for Amplifying the Photothermal Immunotherapy of Gynecologic Malignancy.
ACS Nano
September 2025
State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), School of Chemistry and Life Sciences, College of Electronic and Optical Engineering & College of Flexible Electronics (Future Technol
Gynecologic malignancies are prone to metastasis and recurrence due to the low efficacy and sensitivity of current clinical treatments. Here, we construct ultrasmall Sb@Au nanodots (Sb@Au NDs) as a metallothionein 2A (MT 2A)-silencing nanoagonist for effective photothermal immunotherapy of gynecologic malignancies. Sb@Au NDs show high photothermal conversion efficiency of 56.
View Article and Find Full Text PDFMolecular Motor Matrix-Based Augment Heat Dissipation Strategy Affording Ultrahigh-PCE J-Aggregates for Potentiate Cancer Photothermal Immunotherapy.
Adv Healthc Mater
September 2025
Key Laboratory of Magnetic Molecules and Magnetic Information Materials of Ministry of Education & School of Chemistry and Materials Science of Shanxi Normal University, TaiYuan, 030032, P. R. China.
The photothermal conversion efficiency (PCE) stands as a pivotal determinant in the therapeutic efficacy of photothermal nanoagents (PTNAs) within the context of photothermal therapy (PTT). The dearth of universal strategies to greatly enhance PCE has markedly curtailed the practical deployment of PTNAs. Now this problem is addressed by proposing a universal approach founded on molecular rotors and J-aggregates, "highly efficient molecular motor matrix", to greatly elevate the PCE of traditional PTNAs.
View Article and Find Full Text PDFSynergistic effects of combining phototherapeutics with traditional treatment modalities in oncology.
Chem Commun (Camb)
September 2025
Department of Chemistry, University of Zurich, 8057 Zurich, Switzerland.
Phototherapeutic methods like photodynamic therapy (PDT), photothermal therapy (PTT) and photodecaging have emerged as promising modalities for cancer treatment. Phototherapeutics are activated by light and thereby generate reactive oxygen species (ROS), heat, or release a caged, toxic carry-on. Their distinct advantages of spatial and temporal control preserve healthy tissue while promising a minimal invasive alternative to traditional therapeutic approaches.
View Article and Find Full Text PDFRecent Advancement in MRI-Based Nanotheranostic Agents for Tumor Diagnosis and Therapy Integration.
Int J Nanomedicine
September 2025
Guangxi Key Laboratory of Special Biomedicine; School of Medicine, Guangxi University, Nanning, Guangxi Zhuang Autonomous Region, 530004, People's Republic of China.
Cancer remains one of the leading causes of mortality worldwide. Although conventional treatment strategies such as chemotherapy, radiotherapy, and surgery have demonstrated therapeutic potential, their clinical effectiveness is often limited by poor targeting specificity, systemic toxicity, and inadequate treatment monitoring. Magnetic resonance imaging (MRI) has emerged as a powerful diagnostic modality owing to its non-invasive nature, high spatial resolution, deep tissue penetration, and real-time imaging capabilities, making it particularly suitable for guiding and evaluating cancer therapies.
View Article and Find Full Text PDF